TAS-102 is an orally administered combination of a thymidine-based nucleic acid analogue, trifluridine, and a thymidine phosphorylase inhibitor, tipiracil hydrochloride.
TrustPilot
Reema J.
1 个月前
阿卜杜拉·B.
3 周前
Sneha T.
苏雷什· K.
4天前